Photocure ASA (PHCUF)

Market Cap	152.73M
Revenue (ttm)	51.68M
Net Income (ttm)	-526.97K
Shares Out	n/a
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	114.66
Dividend	n/a
Ex-Dividend Date	n/a

Volume	168
Average Volume	590
Open	5.58
Previous Close	n/a
Day's Range	5.58 - 5.58
52-Week Range	4.32 - 6.00
Beta	0.50
RSI	47.50
Earnings Date	Oct 29, 2025

About Photocure ASA

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced cervical precancerous lesions. The company has a license agreement with Asieris MediTech Co to develop and commercialize Cevira; and a strategic agreemen...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 101
• Stock Exchange: OTCMKTS
• Ticker Symbol: PHCUF

Financial Performance

Financial numbers in NOK